Up-regulation of GTPBP4 is detected in CRC metastatic tissues and closely correlated with tumor metastasis.
Increase of GTPBP4 is closely associated with poor prognosis.
GTPBP4 promotes cell motility and tumor metastasis in CRC cells.
GTPBP4 induces filamentous actin rearrangement specifically by repressing the activity of RhoA.
GTPBP4 may be a novel therapeutic target for CRC patients with metastasis.